Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 10 articles: HTML format

Single Articles

April 2024
1. LIANG JH, Wang WT, Wang R, Gao R, et al
   PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
   Cancer Lett. 2024;591:216877.
   PubMed     Abstract available
   
   
   January 2024
2. WANG WT, Xing TY, Du KX, Hua W, et al
   CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
   Cancer Lett. 2024 Jan 9:216616. doi: 10.1016/j.canlet.2024.216616.
   PubMed     Abstract available
   
   
   October 2022
3. DU Y, Cai Y, Lv Y, Zhang L, et al
   Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
   Cancer Lett. 2022 Oct 17:215972. doi: 10.1016/j.canlet.2022.215972.
   PubMed     Abstract available
   
   
   June 2022
4. WANG K, Wei J, Ma J, Jia Q, et al
   Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth.
   Cancer Lett. 2022;544:215812.
   PubMed     Abstract available
   
   
   April 2022
5. SUN Q, Ye Y, Gui A, Sun X, et al
   MORTALIN-Ca(2+) axis drives innate rituximab resistance in diffuse large B-cell lymphoma.
   Cancer Lett. 2022 Apr 18:215678. doi: 10.1016/j.canlet.2022.215678.
   PubMed     Abstract available
   
   
   January 2022
6. XING Y, Guo W, Wu M, Xie J, et al
   An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo.
   Cancer Lett. 2022 Jan 3. pii: S0304-3835(21)00658.
   PubMed     Abstract available
   
   
   December 2021
7. DANG W, Cao P, Yan Q, Yang L, et al
   IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis.
   Cancer Lett. 2021;523:135-147.
   PubMed     Abstract available
   
   
   October 2021
8. CHEN ZQ, Cao ZR, Wang Y, Zhang X, et al
   Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kalpha against B cell lymphoma.
   Cancer Lett. 2021;524:206-218.
   PubMed     Abstract available
   
   
   
9. COX MC, Bocci G
   Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds.
   Cancer Lett. 2021;524:144-150.
   PubMed     Abstract available
   
   
   September 2021
10. SUN Y, Gao Y, Chen J, Huang L, et al
    CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma.
    Cancer Lett. 2021 Sep 2. pii: S0304-3835(21)00438.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.